Mylan CEO to testify before Congressional committee on EpiPen price hikes
September 14, 2016 at 16:39 PM EDT
Heather Bresch, the CEO of Mylan Pharmaceuticals, will testify before the U.S. Congressional oversight committee on the cost increases for the life-saving EpiPen.